Cell-derived Secretome for the Treatment of Renal Disease
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Kidney disease is a major global health issue. Hemodialysis and kidney transplantation have been used in the clinic to treat renal failure. However, the dialysis is not an effective long-term option, as it is unable to replace complete renal functions. Kidney transplantation is the only permanent treatment for end-stage renal disease (ESRD), but a shortage of implantable kidney tissues limits the therapeutic availability. As such, there is a dire need to come up with a solution that provides renal functions as an alternative to the current standards. Recent advances in cellbased therapy have offered new therapeutic options for the treatment of damaged kidney tissues. Particularly, cell secretome therapy utilizing bioactive compounds released from therapeutic cells holds significant beneficial effects on the kidneys. This review will describe the reno-therapeutic effects of secretome components derived from various types of cells and discuss the development of efficient delivery methods to improve the therapeutic outcomes.
Abstract
Kidney disease is a major global health issue. Hemodialysis and kidney transplantation have been used in the clinic to treat renal failure. However, the dialysis is not an effective long-term option, as it is unable to replace complete renal functions. Kidney transplantation is the only permanent treatment for end-stage renal disease (ESRD), but a shortage of implantable kidney tissues limits the therapeutic availability. As such, there is a dire need to come up with a solution that provides renal functions as an alternative to the current standards. Recent advances in cellbased therapy have offered new therapeutic options for the treatment of damaged kidney tissues. Particularly, cell secretome therapy utilizing bioactive compounds released from therapeutic cells holds significant beneficial effects on the kidneys. This review will describe the reno-therapeutic effects of secretome components derived from various types of cells and discuss the development of efficient delivery methods to improve the therapeutic outcomes.
참고문헌 (83)
- Ko IK, "Principles of Regenerative Medicine", pp.1165~1177, Academic Press
- Moon KH, "Kidney diseases and tissue engineering", Methods, 99, pp.112~119 (2016)
- 조강수, "Bioactive Compounds for the Treatment of Renal Disease", Yonsei Medical Journal, 59(9), pp.1015~1025 (2018), 연세대학교의과대학[DOI]
- Stenvinkel P, "Implantation of Autologous Selected Renal Cells in Diabetic Chronic Kidney Disease Stages 3 and 4-Clinical Experience of a"First in Human"Study", Kidney Int Rep, 1, pp.105~113 (2016)
- Yamaleyeva LM, "Cell Therapy with Human Renal Cell Cultures Containing Erythropoietin-Positive Cells Improves Chronic Kidney Injury", STEM CELLS Transl Med, 1, pp.373~383 (2012)
- Maeshima A, "Regenerative Medicine for the Kidney : Renotropic Factors, Renal Stem", Progenitor Cells, and Stem Cell Therapy, 2014, pp.2014, 1~10
- Tran C, "Stem cells as drug delivery methods: Application of stem cell secretome for regeneration", Adv Drug Deliv Rev, pp.1~11 (2015)
- Herberts CA, "Risk factors in the development of stem cell therapy", J Transl Med, 9, pp.29~ (2011)
- 김현옥, "Mesenchymal Stem Cell-Derived Secretome and Microvesicles as a Cell-Free Therapeutics for Neurodegenerative Disorders", 조직공학과 재생의학, 10(3), pp.93~101 (2013), 한국조직공학과 재생의학회
- Beer L, "Cell secretome based drug substances in regenerative medicine : when regulatory affairs meet basic science", Ann Transl Med, 5, pp.170~ (2017)
- Sun DZ, "Harnessing the mesenchymal stem cell secretome for regenerative urology", Nat Rev Urol, 16, pp.363~375 (2019)
- Pittenger MF, "Multilineage Potential of Adult Human Mesenchymal Stem Cells", Science, 284, pp.143~147 (1999)
- Tsuji K, "Secretomes from Mesenchymal Stem Cells against Acute Kidney Injury: Possible Heterogeneity", Stem Cells International, pp.1~14 (2018)
- Maguire G, "Stem cell therapy without the cells", Commun Integr Biol, 6 (2013)
- Chen L, "Paracrine Factors of Mesenchymal Stem Cells Recruit Macrophages and Endothelial Lineage Cells and Enhance Wound Healing", PLoS One, 3, pp.e1886~ (2008)
- Ciapetti G, "The Combined Use of Mesenchymal Stromal Cells and Scaffolds for Bone Repair", Curr Pharm Des, 18, pp.1796~1820 (2012)
- Senger DR, "Vascular Endothelial Growth Factor : Much More than an Angiogenesis Factor", Mol Biol Cell, 21, pp.377~379 (2010)
- Leung DW, "Vascular endothelial growth factor is a secreted angiogenic mitogen", Science, 246, pp.1306~1309 (1989)
- Kinnaird T, "Local Delivery of Marrow-Derived Stromal Cells Augments Collateral Perfusion Through Paracrine Mechanisms", Circulation, 109, pp.1543~1549 (2004)
- Tögel F, "Vasculotropic, paracrine actions of infused mesenchymal stem cells are important to the recovery from acute kidney injury", Am J Physiol-Ren Physiol, 292, pp.F1626~1635 (2007)
- Rota C, "Human Amniotic Fluid Stem Cell Preconditioning Improves Their Regenerative Potential", Stem Cells Dev, 21, pp.1911~1923 (2012)
- Takahashi M, "Cytokines produced by bone marrow cells can contribute to functional improvement of the infarcted heart by protecting cardiomyocytes from ischemic injury", Am J Physiol-Heart Circ Physiol, 291, pp.H886~93 (2006)
- Bai L, "Human Bone Marrow-derived Mesenchymal Stem Cells Induce Th2-Polarized Immune Response and Promote Endogenous Repair in Animal Models of Multiple Sclerosis", Glia, 57, pp.1192~1203 (2009)
- Duffy MM, "Mesenchymal stem cell inhibition of T-helper 17 cell-differentiation is triggered by cell-cell contact and mediated by prostaglandin E2 via the EP4 receptor", Eur J Immunol, 41, pp.2840~2851 (2011)
- Luz-Crawford P, "Mesenchymal Stem Cell-Derived Interleukin 1Receptor Antagonist Promotes Macrophage Polarization and Inhibits B Cell Differentiation", STEM CELLS, 34, pp.483~492 (2016)
- Sharma R, "Regulatory T cells in acute and chronic kidney diseases", Am J Physiol-Ren Physiol, 314, pp.F679~98 (2018)
- Abedi A, "Effect of Different Times of Intraperitoneal Injections of Human Bone Marrow Mesenchymal Stem Cell Conditioned Medium on Gentamicin-Induced Acute Kidney Injury", Urol J, 13, pp.2707~2716 (2016)
- Da Silva AF, "Bone Marrow-Derived Mesenchymal Stem Cells and Their Conditioned Medium Attenuate Fibrosis in an Irreversible Model of Unilateral Ureteral Obstruction", Cell Transplant, 24, pp.2657~2666 (2015)
- Liu B, "Human umbilical cord-derived mesenchymal stem cells conditioned medium attenuate interstitial fibrosis and stimulate the repair of tubular epithelial cells in an irreversible model of unilateral ureteral obstruction : Conditioned medium in renal fibrosis", Nephrology, 23, pp.728~736 (2018)
- Bollini S, "The Regenerative Role of the Fetal and Adult Stem Cell Secretome", J Clin Med, 2, pp.302~327 (2013)
- Riazifar M, "Stem Cell Extracellular Vesicles : Extended Messages of Regeneration", Annu Rev Pharmacol Toxicol, 57, pp.125~154 (2017)
- Yáñez-Mó M, "Biological properties of extracellular vesicles and their physiological functions", J Extracell Vesicles, 4, pp.27066~ (2015)
- Rad F, "Microvesicles preparation from mesenchymal stem cells", Med J Islam Repub Iran, 30, pp.398~ (2016)
- Record M, "Extracellular vesicles : lipids as key components of their biogenesis and functions", J Lipid Res, 59, pp.1316~1324 (2018)
- Colombo M, "Biogenesis, Secretion, and Intercellular Interactions of Exosomes and Other Extracellular Vesicles", Annu Rev Cell Dev Biol, 30, pp.255~289 (2014)
- Yoo KW, "Large-Scale Preparation of Extracellular Vesicles Enriched with Specific microRNA", Tissue Eng Part C Methods, 24, pp.637~644 (2018)
- Akers JC, "Biogenesis of extracellular vesicles(EV) : exosomes, microvesicles, retrovirus-like vesicles, and apoptotic bodies", J Neurooncol, 113, pp.1~11 (2013)
- Bruno S, "Mesenchymal Stem Cell-Derived Microvesicles Protect Against Acute Tubular Injury", J Am Soc Nephrol, 20, pp.1053~1067 (2009)
- Nargesi AA, "Mesenchymal stem cell-derived extracellular vesicles for renal repair", Curr Gene Ther, 17, pp.29~42 (2017)
- Gatti S, "Microvesicles derived from human adult mesenchymal stem cells protect against ischaemia-reperfusion-induced acute and chronic kidney injury", Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc-Eur Ren Assoc, 26, pp.1474~1483 (2011)
- Reis LA, "Bone marrow-derived mesenchymal stem cells repaired but did not prevent gentamicin-induced acute kidney injury through paracrine effects in rats", PloS One, 7, pp.e44092~ (2012)
- Bruno S, "Microvesicles Derived from Mesenchymal Stem Cells Enhance Survival in a Lethal Model of Acute Kidney Injury", PLoS ONE, 7, pp.33115~ (2012)
- Tomasoni S, "Transfer of Growth Factor Receptor mRNA Via Exosomes Unravels the Regenerative Effect of Mesenchymal Stem Cells", Stem Cells Dev, 22, pp.772~780 (2013)
- Eirin A, "MicroRNA and mRNA cargo of extracellular vesicles from porcine adipose tissue-derived mesenchymal stem cells", Gene, 551, pp.55~64 (2014)
- Ferguson SW, "The microRNA regulatory landscape of MSC-derived exosomes:a systems view", Sci Rep, 8 (2018)
- Lindoso RS, "Extracellular Vesicles Released from Mesenchymal Stromal Cells Modulate miRNA in Renal Tubular Cells and Inhibit ATP Depletion Injury", Stem Cells Dev, 23, pp.1809~1819 (2014)
- Meng X-M, "Disruption of Smad4 impairs TGF-β", Smad3 and Smad7 transcriptional regulation during renal inflammation and fibrosis in vivo and in vitro, 2012, pp.81, 266~279
- Lu J, "Impact of microRNA regulation on variation in human gene expression", Genome Res, 22, pp.1243~1254 (2012)
- Wang B, "Mesenchymal Stem Cells Deliver Exogenous MicroRNA-let7c via Exosomes to Attenuate Renal Fibrosis", Mol Ther, 24, pp.1290~1301 (2016)
- Hu H, "miR-29b regulates Ang II-induced EMT of rat renal tubular epithelial cells via targeting PI3K", AKT signaling pathway, 2018, 42453~42460
- Song N, "miR-21Protects Against Ischemia", Reperfusion-Induced Acute Kidney Injury by Preventing Epithelial Cell Apoptosis and Inhibiting Dendritic Cell Maturation, 2018, 9~
- George SK, "Potential Use of Autologous Renal Cells from Diseased Kidneys for the Treatment of Renal Failure", PLOS ONE, 11, pp.e0164997~ (2016)
- Dominguez JH, "Renal Tubular Cell-Derived Extracellular Vesicles Accelerate the Recovery of Established Renal Ischemia Reperfusion Injury", J Am Soc Nephrol, 28, pp.3533~3544 (2017)
- Drukker M, "Human Embryonic Stem Cells and Their Differentiated Derivatives Are Less Susceptible to Immune Rejection Than Adult Cells", Stem Cells, 24, pp.221~229 (2006)
- Koppen A van, "Human Embryonic Mesenchymal Stem Cell-Derived Conditioned Medium Rescues Kidney Function in Rats with Established Chronic Kidney Disease", PLoS One San Franc, 7, pp.e38746~ (2012)
- Lee PY, "Induced Pluripotent Stem Cells without c-Myc Attenuate Acute Kidney Injury via Downregulating the Signaling of Oxidative Stress and Inflammation in Ischemia-Reperfusion Rats", Cell Transplant, 21, pp.2569~2585 (2012)
- Li LF, "Improvement of ventilator-induced lung injury by IPS cell-derived conditioned medium via inhibition of PI3K", Akt pathway and IP-10-dependent paracrine regulation, 2013, pp.34, 78~91
- Tarng DC, "Induced Pluripotent Stem Cell-Derived Conditioned Medium Attenuates Acute Kidney Injury by Downregulating the Oxidative Stress-Related Pathway in Ischemia-Reperfusion Rats", Cell Transplant, 25, pp.517~530 (2016)
- Urbich C, "Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells", J Mol Cell Cardiol, 39, pp.733~742 (2005)
- Yang Z, "Paracrine factors secreted by endothelial progenitor cells prevent oxidative stress-induced apoptosis of mature endothelial cells", Atherosclerosis, 211, pp.103~109 (2010)
- Cantaluppi V, "Microvesicles derived from endothelial progenitor cells protect the kidney from ischemia-reperfusion injury by microRNAdependent reprogramming of resident renal cells", Kidney Int, 82, pp.412~427 (2012)
- Cantaluppi V, "Endothelial progenitor cell-derived extracellular vesicles protect from complement-mediated mesangial injury in experimental anti-Thy1.1 glomerulonephritis", Nephrol Dial Transplant, 30, pp.410~422 (2015)
- Xing L, "Mesenchymal stem cells, not conditioned medium, contribute to kidney repair after ischemia-reperfusion injury", Stem Cell Res Ther, pp.5~ (2014)
- Pawitan JA, "Prospect of Stem Cell Conditioned Medium in Regenerative Medicine", BioMed Res Int N Y, pp.14~ (2014)
- Yde P, "Modeling the NF-κB mediated inflammatory response predicts cytokine waves in tissue", BMC Syst Biol, 5, pp.115~ (2011)
- Khosravi A, "Determination of the Elimination Half-Life of Fibroblast Growth Factor-23", J Clin Endocrinol Metab, 92, pp.2374~2377 (2007)
- Complex, "PLoS ONE", 2010, e11017~
- Richardson TP, "Polymeric system for dual growth factor delivery", Nat Biotechnol, 19, pp.1029~1034 (2001)
- Chen F-M, "Toward delivery of multiple growth factors in tissue engineering", Biomaterials, 31, pp.6279~6308 (2010)
- Ko IK, "Combined systemic and local delivery of stem cell inducing", recruiting factors for in situ tissue regeneration, 2012, pp.26, 158~168
- Hule RA, "Correlations between structure, material properties and bioproperties in self-assembled β-hairpin peptide hydrogels", Faraday Discuss, 139, pp.251~ (2008)
- Bakota EL, "Injectable Multidomain Peptide Nanofiber Hydrogel as a Delivery Agent for Stem Cell Secretome", Biomacromolecules, 12, pp.1651~1657 (2011)
- Wang Y, "Peptide Nanofibers Preconditioned with Stem Cell Secretome Are Renoprotective", J Am Soc Nephrol, 22, pp.704~717 (2011)
- Porter AG, "Emerging roles of caspase-3 in apoptosis", Cell Death Differ, 6, pp.99~104 (1999)
- Zeng L, "HMG CoA reductase inhibition modulates VEGF-induced endothelial cell hyperpermeability by preventing RhoA activation and myosin regulatory light chain phosphorylation", FASEB J, 19, pp.1845~1852 (2005)
- Waters R, "Stem cell secretome-rich nanoclay hydrogel : a dual action therapy for cardiovascular regeneration", Nanoscale, 8, pp.7371~7376 (2016)
- Yim HE, "Controlled Delivery of Stem Cell-Derived Trophic Factors Accelerates Kidney Repair After Renal Ischemia-Reperfusion Injury in Rats", Stem Cells Transl Med, 8, pp.959~970 (2019)
- Patel AN, "Evaluation of autologous platelet rich plasma for cardiac surgery : outcome analysis of 2000 patients", J Cardiothorac Surg, 11, pp.62~ (2016)
- Li W, "Subcutaneous Injections of Platelet-Rich Plasma into Skin Flaps Modulate Proangiogenic Gene Expression and Improve Survival Rates", Plast Reconstr Surg, 129, pp.858~866 (2012)
- Nassar W, "Umbilical cord mesenchymal stem cells derived extracellular vesicles can safely ameliorate the progression of chronic kidney diseases", Biomater Res, pp.20~ (2016)
- Torres Crigna A, "Stem", Stromal Cells for Treatment of Kidney Injuries With Focus on Preclinical Models, 2018, 5~
- Pires AO, "Unveiling the Differences of Secretome of Human Bone Marrow Mesenchymal Stem Cells, Adipose Tissue-Derived Stem Cells, and Human Umbilical Cord Perivascular Cells : A Proteomic Analysis", Stem Cells Dev, 25, pp.1073~1083 (2016)
- Bruno S, "Extracellular vesicles in renal tissue damage and regeneration", Eur J Pharmacol, 790, pp.83~91 (2016)
